Filing Details

Accession Number:
0001209191-13-027423
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-17 20:07:50
Reporting Period:
2013-05-15
Filing Date:
2013-05-17
Accepted Time:
2013-05-17 20:07:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1333458 Joseph Robert Bujarski 10165 Mckellar Court
San Diego CA 92121
Svp, Bus Dev & Gen Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-15 8,283 $8.50 58,443 No 4 M Direct
Common Stock Disposition 2013-05-15 8,283 $23.35 50,160 No 4 S Direct
Common Stock Acquisiton 2013-05-17 19,196 $8.50 69,356 No 4 M Direct
Common Stock Disposition 2013-05-17 19,196 $23.02 50,160 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2013-05-15 8,283 $0.00 8,283 $8.50
Common Stock Non-Qualified Stock Option Disposition 2013-05-17 19,196 $0.00 19,196 $8.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,004 2013-04-10 2019-04-10 No 4 M Direct
28,808 2013-04-10 2019-04-10 No 4 M Direct
Footnotes
  1. The weighted average purchase price for these transactions was $23.3524 per share, with a range of $23.32 to $23.40 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  2. The weighted average purchase price for these transactions was $23.0229 per share, with a range of $23.01 to $23.10 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.